Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. (2015)

First Author: Dolman ME
Attributed to:  Multimodality Techniques for Cancer Diagnosis and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-15-0313

PubMed Identifier: 26202950

Publication URI: http://europepmc.org/abstract/MED/26202950

Type: Journal Article/Review

Volume: 21

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 22

ISSN: 1078-0432